Published in J Exp Med on February 28, 1947
HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY AMINO ACIDS, PLASMA, HEMOGLOBIN, AND DIGESTS OF SERUM, HEMOGLOBIN, AND CASEIN. J Exp Med (1943) 4.18
TEN AMINO ACIDS ESSENTIAL FOR PLASMA PROTEIN PRODUCTION EFFECTIVE ORALLY OR INTRAVENOUSLY. J Exp Med (1943) 2.91
PLASMA PROTEIN PRODUCTION INFLUENCED BY AMINO ACID MIXTURES AND LACK OF ESSENTIAL AMINO ACIDS : A DEFICIENCY STATE RELATED TO UNKNOWN FACTORS. J Exp Med (1945) 1.79
HEMOGLOBIN AND PLASMA PROTEIN PRODUCTION : VARIOUS PROTEINS, CONCENTRATES, AND DIGESTS INFLUENCE BLOOD PROTEIN PRODUCTION IN ANEMIA AND HYPOPROTEINEMIA. J Exp Med (1946) 1.46
LIVER INJURY, LIVER PROTECTION, AND SULFUR METABOLISM : METHIONINE PROTECTS AGAINST CHLOROFORM LIVER INJURY EVEN WHEN GIVEN AFTER ANESTHESIA. J Exp Med (1942) 1.32
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
I. RENAL THRESHOLDS FOR HEMOGLOBIN IN DOGS : DEPRESSION OF THRESHOLD DUE TO FREQUENT HEMOGLOBIN INJECTIONS AND RECOVERY DURING REST PERIODS. J Exp Med (1932) 9.59
BLOOD PLASMA PROTEIN GIVEN BY VEIN UTILIZED IN BODY METABOLISM : II. A DYNAMIC EQUILIBRIUM BETWEEN PLASMA AND TISSUE PROTEINS. J Exp Med (1934) 8.47
INTESTINAL OBSTRUCTION : VI. A STUDY OF NON-COAGULABLE NITROGEN OF THE BLOOD. J Exp Med (1916) 8.42
RED CELL VOLUME CIRCULATING AND TOTAL AS DETERMINED BY RADIO IRON. Science (1941) 8.25
BLOOD PLASMA PROTEIN REGENERATION CONTROLLED BY DIET : I. LIVER AND CASEIN AS POTENT DIET FACTORS. J Exp Med (1934) 8.08
INFECTION AND INTOXICATION : THEIR INFLUENCE UPON HEMOGLOBIN PRODUCTION IN EXPERIMENTAL ANEMIA. J Exp Med (1936) 6.50
A STUDY OF RENAL FUNCTION IN ROENTGEN RAY INTOXICATION : RESISTANCE OF RENAL EPITHELIUM TO DIRECT RADIATION. J Exp Med (1922) 5.10
II. RENAL FUNCTION INFLUENCED BY PROTEOSE INTOXICATION. J Exp Med (1919) 5.07
BLOOD PLASMA PROTEIN REGENERATION CONTROLLED BY DIET : SYSTEMATIC STANDARDIZATION OF FOOD PROTEINS FOR POTENCY IN PROTEIN REGENERATION. FASTING AND IRON FEEDING. J Exp Med (1935) 4.93
PROTEOSE INTOXICATIONS AND INJURY OF BODY PROTEIN : IV. THE METABOLISM OF DOGS WITH STERILE ABSCESS, PANCREATITIS, AND PLEURITIS. J Exp Med (1918) 4.79
RADIOACTIVE IRON AND ITS METABOLISM IN ANEMIA : ITS ABSORPTION, TRANSPORTATION, AND UTILIZATION. J Exp Med (1939) 4.74
ROENTGEN RAY INTOXICATION : I. UNIT DOSE OVER THORAX NEGATIVE-OVER ABDOMEN LETHAL. EPITHELIUM OF SMALL INTESTINE SENSITIVE TO X-RAYS. J Exp Med (1922) 4.68
HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY AMINO ACIDS, PLASMA, HEMOGLOBIN, AND DIGESTS OF SERUM, HEMOGLOBIN, AND CASEIN. J Exp Med (1943) 4.18
DOG PLASMA PROTEIN GIVEN BY VEIN UTILIZED IN BODY METABOLISM OF DOG : HORSE PLASMA AND DOG HEMOGLOBIN NOT SIMILARLY UTILIZED. J Exp Med (1935) 3.61
VIII. The Experimental Study of Intestinal Obstruction. Ann Surg (1914) 3.59
BLOOD PLASMA PROTEIN REGENERATION CONTROLLED BY DIET : EFFECTS OF PLANT PROTEINS COMPARED WITH ANIMAL PROTEINS THE INFLUENCE OF FASTING AND INFECTION. J Exp Med (1936) 3.59
RADIO-IRON IN PLASMA DOES NOT EXCHANGE WITH HEMOGLOBIN IRON IN RED CELLS. Science (1940) 3.44
BLOOD PLASMA PROTEIN REGENERATION AS INFLUENCED BY INFECTION, DIGESTIVE DISTURBANCES, THYROID, AND FOOD PROTEINS : A DEFICIENCY STATE RELATED TO PROTEIN DEPLETION. J Exp Med (1937) 3.15
V. THE IRON CONTENT OF BLOOD FREE TISSUES AND VISCERA : VARIATIONS DUE TO DIET, ANEMIA AND HEMOGLOBIN INJECTIONS. J Exp Med (1932) 3.02
BILE FISTULAS AND RELATED ABNORMALITIES : BLEEDING, OSTEOPOROSIS, CHOLELITHIASIS AND DUODENAL ULCERS. J Exp Med (1935) 2.96
TEN AMINO ACIDS ESSENTIAL FOR PLASMA PROTEIN PRODUCTION EFFECTIVE ORALLY OR INTRAVENOUSLY. J Exp Med (1943) 2.91
HEMOGLOBIN PRODUCTION IN ANEMIA LIMITED BY LOW PROTEIN INTAKE : INFLUENCE OF IRON INTAKE, PROTEIN SUPPLEMENTS AND FASTING. J Exp Med (1939) 2.82
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. J Clin Oncol (2000) 2.73
RADIOACTIVE IRON ABSORPTION BY GASTRO-INTESTINAL TRACT : INFLUENCE OF ANEMIA, ANOXIA, AND ANTECEDENT FEEDING DISTRIBUTION IN GROWING DOGS. J Exp Med (1943) 2.70
II. HEMOGLOBIN AND BILE PIGMENT OVERPRODUCTION IN THE SPLENECTOMIZED BILE FISTULA DOG. J Exp Med (1935) 2.65
BLOOD PLASMA PROTEIN PRODUCTION AS INFLUENCED BY AMINO ACIDS : CYSTINE EMERGES AS A KEY AMINO ACID UNDER FIXED CONDITIONS. J Exp Med (1939) 2.65
IV. HEMOGLOBIN INJECTIONS AND CONSERVATION OF PIGMENT BY KIDNEY, LIVER AND SPLEEN : THE INFLUENCE OF DIET AND BLEEDING. J Exp Med (1932) 2.61
PLASMA PROTEIN METABOLISM-NORMAL AND ASSOCIATED WITH SHOCK : OBSERVATIONS USING PROTEIN LABELED BY HEAVY NITROGEN IN LYSINE. J Exp Med (1944) 2.59
RED CELL AND PLASMA VOLUMES (CIRCULATING AND TOTAL) AS DETERMINED BY RADIO IRON AND BY DYE. J Exp Med (1942) 2.47
HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY DIET PROTEIN AND OTHER FACTORS. J Exp Med (1940) 2.35
RADIOACTIVE IRON AND ITS EXCRETION IN URINE, BILE, AND FECES. J Exp Med (1939) 2.34
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
I. RENAL FUNCTION INFLUENCED BY INTESTINAL OBSTRUCTION. J Exp Med (1919) 2.25
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
CASEIN DIGESTS PARENTERALLY UTILIZED TO FORM BLOOD PLASMA PROTEIN. J Exp Med (1941) 2.18
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem (1988) 2.15
PROTEOSE INTOXICATIONS AND INJURY OF BODY PROTEIN : V. THE INCREASE IN NON-PROTEIN NITROGEN OF THE BLOOD IN ACUTE INFLAMMATORY PROCESSES AND ACUTE INTOXICATIONS. J Exp Med (1918) 2.11
THE UTILIZATION OF IRON AND THE RAPIDITY OF HEMOGLOBIN FORMATION IN ANEMIA DUE TO BLOOD LOSS. J Exp Med (1940) 2.04
SPLENECTOMY IN BILE FISTULA DOGS : BILE PIGMENT OVERPRODUCTION, ANEMIA AND INTOXICATION. J Exp Med (1933) 1.96
STUDIES ON THE BLOOD PROTEINS : II. THE ALBUMIN-GLOBULIN RATIO IN EXPERIMENTAL INTOXICATIONS AND INFECTIONS. J Exp Med (1917) 1.91
ROENTGEN RAY INTOXICATION : II. A STUDY OF THE SEQUENCE OF CLINICAL, ANATOMICAL, AND HISTOLOGICAL CHANGES FOLLOWING A UNIT DOSE OF X-RAYS. J Exp Med (1922) 1.89
HEMOGLOBIN AND PLASMA PROTEIN : THEIR RELATION TO INTERNAL BODY PROTEIN METABOLISM. J Exp Med (1945) 1.87
PLASMA PROTEIN PRODUCTION INFLUENCED BY AMINO ACID MIXTURES AND LACK OF ESSENTIAL AMINO ACIDS : A DEFICIENCY STATE RELATED TO UNKNOWN FACTORS. J Exp Med (1945) 1.79
Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc (1997) 1.69
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients. Drug Metab Dispos (2000) 1.67
MARROW HYPERPLASIA AND HEMOGLOBIN RESERVE IN EXPERIMENTAL ANEMIA DUE TO BLEEDING. J Exp Med (1932) 1.64
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE. J Exp Med (1946) 1.61
LIVER FUNCTION AND BLOOD PLASMA PROTEIN FORMATION : NORMAL AND ECK FISTULA DOGS. J Exp Med (1937) 1.56
PERITONEAL ABSORPTION : RED CELLS LABELED BY RADIO-IRON HEMOGLOBIN MOVE PROMPTLY FROM PERITONEAL CAVITY INTO THE CIRCULATION. J Exp Med (1944) 1.55
ROENTGEN RAY INTOXICATION : I. BACTERIAL INVASION OF THE BLOOD STREAM AS INFLUENCED BY X-RAY DESTRUCTION OF THE MUCOSAL EPITHELIUM OF THE SMALL INTESTINE. J Exp Med (1923) 1.48
HEMOGLOBIN AND PLASMA PROTEIN PRODUCTION : VARIOUS PROTEINS, CONCENTRATES, AND DIGESTS INFLUENCE BLOOD PROTEIN PRODUCTION IN ANEMIA AND HYPOPROTEINEMIA. J Exp Med (1946) 1.46
VALUE OF ANIMAL EXPERIMENTATION TO MANKIND. Am J Public Health (N Y) (1921) 1.46
Thermal injury and recovery of Bacillus subtilis. Appl Microbiol (1972) 1.45
AMINO ACID MIXTURES EFFECTIVE PARENTERALLY FOR LONG CONTINUED PLASMA PROTEIN PRODUCTION. CASEIN DIGESTS COMPARED. J Exp Med (1944) 1.41
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer (1999) 1.41
RAIDING OF BODY TISSUE PROTEIN TO FORM PLASMA PROTEIN AND HEMOGLOBIN : WHAT IS PREMORTAL RISE OF URINARY NITROGEN? J Exp Med (1947) 1.40
Stopping a clinical trial very early because of toxicity: summarizing the evidence. Control Clin Trials (1993) 1.39
BLOOD PLASMA PROTEIN PRODUCTION AND UTILIZATION : THE INFLUENCE OF AMINO ACIDS AND OF STERILE ABSCESSES. J Exp Med (1940) 1.36
LIVER INJURY, LIVER PROTECTION, AND SULFUR METABOLISM : METHIONINE PROTECTS AGAINST CHLOROFORM LIVER INJURY EVEN WHEN GIVEN AFTER ANESTHESIA. J Exp Med (1942) 1.32
TOLERANCE TO AMINO ACID MIXTURES AND CASEIN DIGESTS GIVEN INTRAVENOUSLY : GLUTAMIC ACID RESPONSIBLE FOR REACTIONS. J Exp Med (1945) 1.30
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist (2001) 1.29
HEMOGLOBIN PRODUCTION IN ANEMIA AS INFLUENCED BY THE BILE FISTULA. J Exp Med (1938) 1.23
PLASMA PROTEIN PRODUCTION AS INFLUENCED BY PARENTERAL PROTEIN DIGESTS, VERY HIGH PROTEIN FEEDING, AND RED BLOOD CELL CATABOLISM. J Exp Med (1945) 1.22
Remote real-time diagnosis of clinical electrocardiograms by a digital computer system. Ann N Y Acad Sci (1965) 1.20
Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull (1983) 1.19
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res (1987) 1.18
The effect of perfusate pH on glutamine metabolism in the isolated perfused rat liver. J Biol Chem (1970) 1.18
GLOBIN UTILIZATION BY THE ANEMIC DOG TO FORM NEW HEMOGLOBIN. J Exp Med (1937) 1.15
RADIOACTIVE IRON ABSORPTION IN CLINICAL CONDITIONS: NORMAL, PREGNANCY, ANEMIA, AND HEMOCHROMATOSIS. J Exp Med (1942) 1.15
Congestive heart failure following chronic tachycardia. Am Heart J (1971) 1.15
The functional significance of changes in activity of the enzymes, tryptophan pyrrolase and tyrosine transaminase, after induction in intact rats and in the isolated, perfused rat liver. J Biol Chem (1969) 1.14
A CASEIN DIGEST BY VEIN UTILIZED TO FORM BLOOD PLASMA PROTEIN. Science (1941) 1.12
Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J (1989) 1.11
II. APLASIA OF MARROW AND FATAL INTOXICATION IN DOGS PRODUCED BY ROENTGEN RADIATION OF ALL BONES. J Exp Med (1931) 1.10
Effect of whole x-irradiation of rats on net synthesis of albumin, fibrinogen, alpha-1-acid glycoprotein, and alpha-2-globulin (acute phase globulin) by the isolated, perfused rat liver. J Biol Chem (1968) 1.08
BLOOD PLASMA PROTEIN PRODUCTION AS INFLUENCED BY VARIOUS DEGREES OF HYPOPROTEINEMIA AND BY AMINO ACIDS. J Exp Med (1941) 1.07
Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem (1991) 1.06
Infraputaminal 'lacunes'. Clinical and pathological correlations. Stroke (1995) 1.06
The PREP system of nursing interventions: a pilot test with families caring for older members. Preparedness (PR), enrichment (E) and predictability (P). Res Nurs Health (1995) 1.06
Measurement of pepsin I (gastricsin) in human gastric juice. Gastroenterology (1967) 1.06
ANEMIA AND HYPOPROTEINEMIA : WEIGHT MAINTENANCE EFFECTED BY FOOD PROTEINS BUT NOT BY MIXTURES OF PURE AMINO ACIDS. J Exp Med (1947) 1.05
Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry (1983) 1.04
Influence of actinomycin D and puromycin on net synthesis of plasma albumin and fibrinogen by the isolated perfused rat liver. J Biol Chem (1966) 1.02
Coronary risk and estrogen use in postmenopausal women. Am J Epidemiol (1978) 1.02
Missing quasiparticles and the chemical potential puzzle in the doping evolution of the cuprate superconductors. Phys Rev Lett (2004) 1.02
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. Clin Cancer Res (2000) 1.00
A comparison of measures of reading and intelligence as risk factors for the development of myopia in a UK cohort of children. Br J Ophthalmol (2008) 1.00
Studies of human intrinsic factor auto-antibodies. J Immunol (1966) 0.96
Genome-wide association study of shared components of reading disability and language impairment. Genes Brain Behav (2013) 0.95